Healthcare -
Biotechnology - NASDAQ - BM
$ 20.28
3.31 %
$ 1.47 B
Market Cap
-33.8
P/E
KNSA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities KNSA - Kiniksa Pharmaceuticals, Ltd.
1.5 M
LAST VALUE
-49.60%
2 YEAR CAGR
-66.35%
5 YEAR CAGR
0.00%
10 YEAR CAGR